Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

4Global to quit Aim, warns on profits

(Sharecast News) - 4Global is to quit Aim and go private, the sports data specialist announced on Wednesday, after failing to raise enough capital to fund long-term growth plans. Shares in the business - which also warned on profits - had plunged 44% to 12.34p as at 1215 BST.

4Global said that having recently reviewed plans to grow the company, it no longer believed that a listing on Aim was in shareholders' best interests.

In particular, it flagged the costs of being a listed firm - which it called "disproportionately high compared with the benefits" - a lack of liquidity and its struggling share price, which has negatively impact its market value.

The stock reached a high of 95p shortly after debuting in December 2021, at 89p. But within weeks it had fallen back and has failed to trade above its debut price ever since.

4Global also said attempts to raise sufficient additional equity capital had failed, and refinancing deadlines were due later this year.

The firm, which was founded in 2002, also warned that annual revenues and adjusted earnings would come in below expectations.

Updating on trading in March, 4Global had said revenues would likely come in between £5.1m and £5.3m, and earnings before interest, tax, appreciation around £900,000 to £1.0m.

However, it now expects to post revenues of £4.5m in the year to 31 March, and EBITDA of £500,000.

Trading had been "volatile", it said, with macroeconomic factors affecting the timing of contracts.

However, it noted that two contracts - with Sport England and UK Sport - had been secured since the year end, and that booked revenues for the current year was up 24% as a result, at £3.1m.

Shareholders will be able to vote on the plans to delist at a meeting on 25 June. Should the resolution pass, the last day of trading will likely be 4 July. It will then re-register as a private company on 28 July.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.